Steve Miller, Chief Operating Officer at CATALYST PHARMACEUTICAL PARTNERS, INC. (CPRX), bought 100,000 shares at $2.17 ($217K) on 2014-06-04, disclosed to the SEC on 2014-06-04.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| CPRX | SELL | 2024-08-22 | $4.1M | — | Filing → |
| CPRX | SELL | 2023-12-07 | $570K | — | Filing → |
| CPRX | SELL | 2022-11-23 | $1.6M | — | Filing → |